Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ).
Fisher & Paykel Healthcare Corporation Limited disclosed a change in the shareholding of its director, Graham Andrew McLean, who increased his beneficial interest by purchasing 1,000 ordinary shares, bringing his total to 2,900 shares. This transaction indicates a personal investment by the director in the company, potentially reflecting confidence in the company’s future performance and may influence stakeholders’ perception of the company’s market stability.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited operates in the healthcare industry, specializing in the production of medical devices and products that focus on respiratory care and acute care therapies. The company is known for its innovative solutions in the health sector, aiming to improve patient care and outcomes globally.
YTD Price Performance: -22.94%
Average Trading Volume: 1,147
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $11.8B
Find detailed analytics on FSPKF stock on TipRanks’ Stock Analysis page.
